Immunohistochemical analysis of P53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran

被引:170
作者
Moghaddam, S. J.
Haghighi, E. N.
Samiee, S.
Shahid, N.
Keramati, A. R.
Dadgar, S.
Zali, M. R.
机构
[1] Shahid Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran 19857, Iran
[2] Acad Med Sci, Tehran, Iran
关键词
hepatocellular carcinoma; Iran; expression of p53; cyclinD1; RB1; c-fos and N-ras genes;
D O I
10.3748/wjg.v13.i4.588
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study the effect of some genes especially those involved in cell cycle regulation on hepatocellular carcinoma. METHODS: Paraffin-em bedded tissue samples of 25 patients (18 males and 7 females) with hepatocellular carcinoma were collected from 22 pathology centers in Tehran during 2000-2001, and stained using immunohistochemistry method (avidin-biotin-peroxidase) for detection of p53, cyclinD1, RB1, c-fos and N-ras proteins. RESULTS: Six (24%), 5 (20%), 12 (48%) and 2 samples (8%) were positive for p53, cyclinD1, C-fos and N-ras expression, respectively. Twenty-two (88%) samples had alterations in the G1 cell-cycle checkpoint protein expression (RB1 or cyclinD1). P53 positive samples showed a higher (9 times) risk of being positive for RB1 protein than p53 negative samples. Loss of expression of RB1 in association with p53 over-expression was observed in 4 (66.7%) of 6 samples. Loss of expression of RB1 was seen in all cyclinD1 positive, 20 (90.9%) N-ras negative, and 11 (50%) C-fos positive samples, respectively. CyclinD1 positive samples showed a higher (2.85 and 4.75 times) risk of being positive for c-fos and N-ras expression than cyclinD1 negative samples. CONCLUSION: The expression of p53, RB1 and c-fos genes appears to have a key role in the pathogenesis of hepatocellular carcinoma in Iran. Simultaneous overexpression of these genes is significantly associated with their loss of expression during development of hepatocellular carcinoma. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 49 条
[1]
Adibi P, 2004, SAUDI MED J, V25, P1414
[2]
Tumor heterogeneity in small hepatocellular carcinoma:: Analysis of tumor cell proliferation, expression and mutation of p53 and β-catenin [J].
An, FQ ;
Matsuda, M ;
Fujii, H ;
Tang, RF ;
Amemiya, H ;
Dai, YM ;
Matsumoto, Y .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) :468-474
[3]
[Anonymous], PRIMARY LIVER CANC J
[4]
ARBUTHNOT P, 1991, ANTICANCER RES, V11, P921
[5]
Ashida K, 1997, J CANCER RES CLIN, V123, P489
[6]
Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas [J].
Azechi, H ;
Nishida, N ;
Fukuda, Y ;
Nishimura, T ;
Minata, M ;
Katsuma, H ;
Kuno, M ;
Ito, T ;
Komeda, T ;
Kita, R ;
Takahashi, R ;
Nakao, K .
ONCOLOGY, 2001, 60 (04) :346-354
[7]
Bjersing L, 1996, CANCER EPIDEM BIOMAR, V5, P393
[8]
Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185
[9]
CERUTTI P, 1994, CANCER RES, V54, pS1934
[10]
Chao HK, 1999, MOL CARCINOGEN, V26, P69, DOI 10.1002/(SICI)1098-2744(199910)26:2&lt